Table 1.
Retinopathy | Proliferative retinopathy | STDR | Neuropathy | Nephropathy | Renal failure | CVD | DKA | Outpatient hypoglycaemia | Hospitalised hypoglycaemia | |
No of cases* | 3359 | 3970 | 3983 | 3742 | 3634 | 4003 | 3916 | 2205 | 3934 | 3987 |
1532 | 157 | 90 | 558 | 688 | 36 | 117 | 996 | 913 | 105 | |
Follow-up time (person-years)† | 15 675 | 26 733 | 27 139 | 23 320 | 21 936 | 27 491 | 26 664 | 8224 | 22 865 | 26 968 |
Incidence density (1000 person-years) (95% CI) |
97.74 (92.9 to 102.8) |
5.87 (5.0 to 6.9) |
3.32 (2.7 to 4.1) |
23.93 (22.0 to 26.0) |
31.36 (29.1 to 33.8) |
1.31 (0.9 to 1.8) |
4.39 (3.6 to 5.3) |
121.11 (113.7 to 128.9) |
39.93 (37.4 to 42.6) |
3.89 (3.2 to 4.7) |
Patients with type 1 diabetes were retrieved from incident cases from 2000 to 2012. Follow-up time started from the first diagnosis date to the time the event occurred, death, discontinued enrolment from Taiwan’s National Health Insurance Programme, or the end of 2013, whichever came first.
*No of cases refers to the number of patients who had no complication of interest in the baseline year (1 year before diagnosis date).
†No of cases with event refers to the number of patients who had incident events after type 1 diabetes was confirmed.
‡Cumulative follow-up time (person-years) was calculated as the sum of follow-up years during observation period.
CVD, cardiovascular disease, DKA, diabetic ketoacidosis; STDR, sight-threatening diabetic retinopathy.